Pulike Biological Engineering, Inc. (SHA:603566)
China · Delayed Price · Currency is CNY 13.82
-0.08 (-0.58%)
At close: Feb 13, 2026
SHA:603566 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 143.67 | 92.81 | 174.52 | 167.82 | 244.14 | 227.74 |
Depreciation & Amortization | 120.18 | 120.18 | 92.73 | 74.84 | 59.46 | 51.05 |
Other Amortization | 2.11 | 2.11 | 0.53 | 0.48 | - | 0.16 |
Loss (Gain) From Sale of Assets | 11.35 | 11.35 | 0.41 | 0.21 | 0.71 | 0.68 |
Asset Writedown & Restructuring Costs | 1.93 | 1.93 | 0.23 | 0.33 | 2.63 | 0.05 |
Loss (Gain) From Sale of Investments | 8.31 | 8.31 | 0.03 | 19.93 | -20.39 | -35.7 |
Provision & Write-off of Bad Debts | -5.27 | -5.27 | 27.66 | 15.33 | 8.24 | 9.12 |
Other Operating Activities | 100.93 | 0.5 | -3.11 | 4.91 | 0.22 | 0.02 |
Change in Accounts Receivable | 88.95 | 88.95 | -6.43 | -219.23 | -102.27 | -57.07 |
Change in Inventory | -9.99 | -9.99 | 7.89 | -19.67 | -36.75 | -15.76 |
Change in Accounts Payable | -40.06 | -40.06 | -16.43 | 198.59 | 44.3 | 77.86 |
Change in Other Net Operating Assets | 0.93 | 0.93 | 5.06 | -5.95 | 9.06 | -0.19 |
Operating Cash Flow | 420.08 | 268.79 | 282.78 | 228.36 | 212.53 | 261.83 |
Operating Cash Flow Growth | 91.07% | -4.95% | 23.83% | 7.45% | -18.83% | 86.89% |
Capital Expenditures | -82.33 | -121.06 | -304.98 | -357.16 | -317.54 | -177.14 |
Sale of Property, Plant & Equipment | 2.02 | 2.22 | 0.43 | 0.45 | 1.07 | 0.92 |
Cash Acquisitions | - | - | -23.14 | - | - | - |
Investment in Securities | -188.85 | -78.78 | 299.6 | -625.75 | 177.6 | 52.71 |
Other Investing Activities | 8.54 | 9.35 | 26.43 | 27.27 | 8.36 | 15.77 |
Investing Cash Flow | -260.63 | -188.26 | -1.66 | -955.19 | -130.51 | -107.74 |
Short-Term Debt Issued | - | - | - | 37 | - | - |
Total Debt Issued | - | - | - | 37 | - | - |
Short-Term Debt Repaid | - | - | -7 | -30 | - | - |
Long-Term Debt Repaid | - | -0.88 | -0.71 | - | - | - |
Total Debt Repaid | -0.88 | -0.88 | -7.71 | -30 | - | - |
Net Debt Issued (Repaid) | -0.88 | -0.88 | -7.71 | 7 | - | - |
Issuance of Common Stock | - | - | - | 892.42 | - | - |
Repurchase of Common Stock | -52.7 | -52.7 | -7.64 | - | - | -133.55 |
Common Dividends Paid | -136.77 | -137.85 | -225 | -63.65 | -157.32 | -63.18 |
Other Financing Activities | 52.63 | -0.14 | -0.67 | -3.03 | -0.25 | - |
Financing Cash Flow | -137.71 | -191.56 | -241.03 | 832.74 | -157.57 | -196.73 |
Foreign Exchange Rate Adjustments | -0.07 | 0.01 | 0.31 | 0.34 | -0.22 | -0 |
Net Cash Flow | 21.66 | -111.02 | 40.4 | 106.25 | -75.76 | -42.64 |
Free Cash Flow | 337.75 | 147.73 | -22.2 | -128.8 | -105.01 | 84.69 |
Free Cash Flow Growth | 298.27% | - | - | - | - | 54.19% |
Free Cash Flow Margin | 30.60% | 14.17% | -1.77% | -10.47% | -9.56% | 9.12% |
Free Cash Flow Per Share | 0.98 | 0.43 | -0.06 | -0.40 | -0.34 | 0.27 |
Cash Income Tax Paid | 59.23 | 68.11 | 101.94 | 62.05 | 79.92 | 71.04 |
Levered Free Cash Flow | 292.14 | 95.89 | -121.29 | -190.31 | -192.46 | -7.9 |
Unlevered Free Cash Flow | 293.25 | 95.95 | -120.71 | -189.77 | -192.46 | -7.9 |
Change in Working Capital | 36.88 | 36.88 | -10.21 | -55.49 | -82.47 | 8.69 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.